TABLE 1.

Patients’ characteristics.

	Hormones + RT Whole Pelvis+Boost(n=280)		Hormones + RT Prostate Alone(n=269)		RT Whole Pelvis+Boost + Hormones(n=260)		RT Prostate Alone + Hormones(n=261)
Age (year)
Median	70		70		70		70
Range	46–83		44–87		50–84		45–85
PSA (ng/mL)
Median	23.1		22.9		22.1		23.9
Range	2.9–97.6		4.1–95.1		3.0–98.0		4.1–98.2
	n	%	n	%	n	%	n	%
T-Stage
T1c,T2a	66	24	68	25	52	20	56	21
T1b,T2b	29	10	30	11	20	8	33	13
T2c-T4	185	66	171	64	188	72	172	66
Baseline PSA
<30	190	68	183	68	169	65	179	69
≥30	90	32	86	32	91	35	82	31
≥20	116	41	116	43	113	43	111	43
>20	164	59	153	57	147	57	150	57
≤10	48	17	53	20	47	18	59	23
>10	232	83	216	80	213	82	202	77
Gleason (Institutional)
2–6	71	25	74	28	70	27	69	26
7	130	46	124	46	111	43	108	41
8–10	79	28	71	26	79	30	84	32
Karnofsky status
70	4	1	3	1	3	1	6	2
80	22	8	15	6	16	6	16	6
90	123	44	122	45	107	41	107	41
100	131	47	129	48	134	52	132	51
Race
White	202	72	191	71	193	74	183	70
African American	63	23	67	25	54	21	67	26
Hispanic or Latino	7	3	4	1	9	3	8	3
Other	7	3	4	1	4	2	2	1
Unknown	1	<1	3	1	0	0	1	<1
Baseline
Testosterone Status
Normal	236	84	215	80	214	82	204	78
Abnormal	44	16	54	20	46	18	57	22